Journal of Translational Medicine (Sep 2022)
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
- Jonathan T. Sims,
- Ching-Yun Chang,
- Josh Poorbaugh,
- Montanea Daniels,
- Stephanie L. Beasley,
- Lin Zhang,
- George H. Rodgers,
- Fabio Lena,
- Leonardo G. Lacerenza,
- Bruno Sposato,
- Annabelle Dupont,
- Sophie Susen,
- Giacomo Casalini,
- Mario Corbellino,
- Justin Stebbing,
- Venkatesh Krishnan
Affiliations
- Jonathan T. Sims
- Eli Lilly and Company, Lilly Corporate Center
- Ching-Yun Chang
- Eli Lilly and Company, Lilly Corporate Center
- Josh Poorbaugh
- Eli Lilly and Company, Lilly Corporate Center
- Montanea Daniels
- Eli Lilly and Company, Lilly Corporate Center
- Stephanie L. Beasley
- Eli Lilly and Company, Lilly Corporate Center
- Lin Zhang
- Eli Lilly and Company, Lilly Corporate Center
- George H. Rodgers
- Eli Lilly and Company, Lilly Corporate Center
- Fabio Lena
- Department of Pharmaceutical Medicine, Misericordia Hospital
- Leonardo G. Lacerenza
- Department of Pharmaceutical Medicine, Misericordia Hospital
- Bruno Sposato
- Department of Pharmaceutical Medicine, Misericordia Hospital
- Annabelle Dupont
- Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille
- Sophie Susen
- Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, University of Lille
- Giacomo Casalini
- Luigi Sacco Department of Clinical and Biomedical Sciences, University of Milan
- Mario Corbellino
- Division of Infectious Diseases, ASST Fatebenefratelli Sacco
- Justin Stebbing
- Department of Surgery and Cancer, Imperial College
- Venkatesh Krishnan
- Eli Lilly and Company, Lilly Corporate Center
- DOI
- https://doi.org/10.1186/s12967-022-03583-5
- Journal volume & issue
-
Vol. 20,
no. 1
pp. 1 – 3
Abstract
No abstracts available.Keywords
